217 related articles for article (PubMed ID: 28375864)
21. Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and management.
Bade NA; Lu C; Patzke CL; Baer MR; Duong VH; Law JY; Lee ST; Sausville EA; Zimrin AB; Duffy AP; Lawson J; Emadi A
J Oncol Pharm Pract; 2020 Jan; 26(1):74-92. PubMed ID: 30917738
[TBL] [Abstract][Full Text] [Related]
22. The Characteristics and Risk Factors of Asparaginase-Associated Pancreatitis in Pediatric Acute Lymphoblastic Leukemia.
Kuo SH; Chen JS; Cheng CN; Lo HY; Chen WC; Lai FP; Yang YJ
Pancreas; 2022 Apr; 51(4):366-371. PubMed ID: 35695827
[TBL] [Abstract][Full Text] [Related]
23. Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocol.
Wolthers BO; Frandsen TL; Abrahamsson J; Albertsen BK; Helt LR; Heyman M; Jónsson ÓG; Kõrgvee LT; Lund B; Raja RA; Rasmussen KK; Taskinen M; Tulstrup M; Vaitkevičienė GE; Yadav R; Gupta R; Schmiegelow K
Leukemia; 2017 Feb; 31(2):325-332. PubMed ID: 27451978
[TBL] [Abstract][Full Text] [Related]
24. Asparaginase-Associated Pancreatitis in Pediatric Patients with Acute Lymphoblastic Leukemia: Current Perspectives.
Gibson A; Hernandez C; Tejada FNH; Kawedia J; Rytting M; Cuglievan B
Paediatr Drugs; 2021 Sep; 23(5):457-463. PubMed ID: 34351604
[TBL] [Abstract][Full Text] [Related]
25. Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen.
Christ TN; Stock W; Knoebel RW
J Oncol Pharm Pract; 2018 Jun; 24(4):299-308. PubMed ID: 28355969
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic panniculitis caused by L-asparaginase induced acute pancreatitis in a child with acute lymphoblastic leukemia.
Chiewchengchol D; Wananukul S; Noppakun N
Pediatr Dermatol; 2009; 26(1):47-9. PubMed ID: 19250405
[TBL] [Abstract][Full Text] [Related]
27. Toxicity profile of repeated doses of PEG-asparaginase incorporated into a pediatric-type regimen for adult acute lymphoblastic leukemia.
Aldoss I; Douer D; Behrendt CE; Chaudhary P; Mohrbacher A; Vrona J; Pullarkat V
Eur J Haematol; 2016 Apr; 96(4):375-80. PubMed ID: 26095294
[TBL] [Abstract][Full Text] [Related]
28. L-asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia.
Sahu S; Saika S; Pai SK; Advani SH
Pediatr Hematol Oncol; 1998; 15(6):533-8. PubMed ID: 9842647
[TBL] [Abstract][Full Text] [Related]
29. PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol.
Henriksen LT; Harila-Saari A; Ruud E; Abrahamsson J; Pruunsild K; Vaitkeviciene G; Jónsson ÓG; Schmiegelow K; Heyman M; Schrøder H; Albertsen BK;
Pediatr Blood Cancer; 2015 Mar; 62(3):427-33. PubMed ID: 25418987
[TBL] [Abstract][Full Text] [Related]
30. [Activity of Erwinia-asparaginase after anaphylactic reaction to Peg-asparaginase].
Viña Romero MM; García Gil S; Nazco Casariego GJ; Merino Alonso J; Gutiérrez Nicolás F
An Pediatr (Engl Ed); 2019 Mar; 90(3):187-188. PubMed ID: 29705180
[No Abstract] [Full Text] [Related]
31. Acid-suppressing Drugs and a Low 1 Level of Antithrombin as Risk Factors for L-Asparaginase-associated Pancreatitis: A Case-control Study in the Japan Association of Childhood Leukemia Study (JACLS).
Hashii Y; Yoshida M; Hara J; Nishimura S; Yumura-Yagi K; Horibe K; Nakahata T
J Pediatr Hematol Oncol; 2018 Jul; 40(5):374-378. PubMed ID: 29697579
[TBL] [Abstract][Full Text] [Related]
32. Successful use of octreotide as a chemoprotectant for prevention of PEG-asparaginase-induced pancreatitis.
Buie LW; Moore J; van Deventer H
Pharmacotherapy; 2014 Aug; 34(8):e149-51. PubMed ID: 25112526
[TBL] [Abstract][Full Text] [Related]
33. Asparaginase-associated toxicity in children with acute lymphoblastic leukemia.
Hijiya N; van der Sluis IM
Leuk Lymphoma; 2016; 57(4):748-57. PubMed ID: 26457414
[TBL] [Abstract][Full Text] [Related]
34. Asparaginase-associated pancreatitis in children.
Raja RA; Schmiegelow K; Frandsen TL
Br J Haematol; 2012 Oct; 159(1):18-27. PubMed ID: 22909259
[TBL] [Abstract][Full Text] [Related]
35. Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis.
Kearney SL; Dahlberg SE; Levy DE; Voss SD; Sallan SE; Silverman LB
Pediatr Blood Cancer; 2009 Aug; 53(2):162-7. PubMed ID: 19405141
[TBL] [Abstract][Full Text] [Related]
36. Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia.
Earl M
Clin Adv Hematol Oncol; 2009 Sep; 7(9):600-6. PubMed ID: 20020672
[TBL] [Abstract][Full Text] [Related]
37. [Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase].
Wlazłowski M; Celińska W; Maciejka-Kapuścińska L; Płoszyńska A; Idczak E
Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):296-7. PubMed ID: 7808958
[TBL] [Abstract][Full Text] [Related]
38. Pancreas-related persisting sequelae in ALL survivors with a history of asparaginase-associated pancreatitis: A part of the ALL-STAR study.
Skipper MT; Birkebæk N; Jensen RB; Rank CU; Tuckuviene R; Wehner PS; Lambine TL; Hørlyck A; Schmiegelow K; Frandsen TL; Andrés-Jensen L; Albertsen BK
Eur J Haematol; 2024 Jun; 112(6):944-956. PubMed ID: 38351310
[TBL] [Abstract][Full Text] [Related]
39. A systems approach points to a therapeutic role for retinoids in asparaginase-associated pancreatitis.
Tsai CY; Saito T; Sarangdhar M; Abu-El-Haija M; Wen L; Lee B; Yu M; Lipata DA; Manohar M; Barakat MT; Contrepois K; Tran TH; Theoret Y; Bo N; Ding Y; Stevenson K; Ladas EJ; Silverman LB; Quadro L; Anthony TG; Jegga AG; Husain SZ
Sci Transl Med; 2023 Mar; 15(687):eabn2110. PubMed ID: 36921036
[TBL] [Abstract][Full Text] [Related]
40. [Advances on the role of pegaspargase in the treatment of childhood leukemia].
Liu L; Xie XT
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):155-60. PubMed ID: 24568909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
